Cytomegalovirus infection epidemiology and demographics

Cytomegalovirus infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cytomegalovirus infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cytomegalovirus infection epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cytomegalovirus infection epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cytomegalovirus infection epidemiology and demographics
CDC on Cytomegalovirus infection epidemiology and demographics
Cytomegalovirus infection epidemiology and demographics in the news
Blogs on Cytomegalovirus infection epidemiology and demographics
Directions to Hospitals Treating Cytomegalovirus infection
Risk calculators and risk factors for Cytomegalovirus infection epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

Cytomegalovirus infection is seen approximately 40-90% of the world population.

Epidemiology and Demographics

Prevalence

• Cytomegalovirus (CMV) infects approximately 40-90% of the world population.
• CMV seroprevalence in developing countries reaches more than 90% by adolescence and exceeds 95% by early adulthood.
• In the United States, 35%-90% of women entering their childbearing years are seropositive, and thus, they are not susceptible to primary CMV infection.

Age

• Seroprevalence is age-dependent 58.9% of individuals aged 6 and over are infected with CMV.
• 90.8% of individuals aged 80 and over are positive for CMV.